Exosome Diagnostics, A Bio-Techne Brand

Exosome Diagnostics, A Bio-Techne Brand company information, Employees & Contact Information

Exosome Diagnostics, Inc. is commercializing minimally invasive molecular diagnostics in blood and urine to enable doctors to select optimal therapies for cancer and other diseases. Exosomes are lipid bilayer covered microvesicles shed by solid tumors into body fluids, such as blood and urine. Exosomes contain nucleic acid profiles of cancers and other diseases. In published studies, Exosome Diagnostics has demonstrated the ability to extract exosomes from the blood and urine of patients, and to detect with high sensitivity and specificity key genes and gene mutations associated with a variety of cancers.

Company Details

Employees
98
Founded
-
Address
266 Second Ave, Suite 200, Waltham,ma 02451,united States
Phone
1(617) 588-0500
Email
in****@****edx.com
Industry
Biotechnology Research
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)
HQ
Waltham, MA
Looking for a particular Exosome Diagnostics, A Bio-Techne Brand employee's phone or email?

Exosome Diagnostics, A Bio-Techne Brand Questions

News

Exosome Diagnostics Announces National Medicare - GlobeNewswire

Exosome Diagnostics Announces National Medicare GlobeNewswire

New Products: Test launched to improve prostate biopsy decision process - Urology Times

New Products: Test launched to improve prostate biopsy decision process Urology Times

ExoDx prostate test as a predictor of outcomes of high-grade prostate cancer – an interim analysis - Nature

ExoDx prostate test as a predictor of outcomes of high-grade prostate cancer – an interim analysis Nature

Thermo Fisher Scientific Deal Expands Possibilities for Exosome Dx Business, Bio-Techne CEO Says - Precision Medicine Online

Thermo Fisher Scientific Deal Expands Possibilities for Exosome Dx Business, Bio-Techne CEO Says Precision Medicine Online

Bio-Techne to pay up to $575M for liquid biopsy maker Exosome Diagnostics - Fierce Biotech

Bio-Techne to pay up to $575M for liquid biopsy maker Exosome Diagnostics Fierce Biotech

Exosomes—the next frontier in biomarker discovery and diagnostics - Nature

Exosomes—the next frontier in biomarker discovery and diagnostics Nature

Bio-Techne buying 'liquid biopsy' firm Exosome for $250M+ - The Business Journals

Bio-Techne buying 'liquid biopsy' firm Exosome for $250M+ The Business Journals

Top Exosome Diagnostics, A Bio-Techne Brand Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant